Mar 11, 2021
This episode details how psoriatic arthritis and the spondyloarthropathies came to be recognized as a distinct clinical entity after decades of nerdy arguing.
Brought to you by Actemra.
- Intro :10
- Shout out to Cleveland Clinic Biologic Therapies Summit :30
- In this episode 1:29
- A 30,000-foot view 2:34
- When did PsA separate from rheumatoid arthritis? 3:34
- Mary Stults Sherman 7:11
- Verna Wright and Dr. John Moll put PsA on the map 9:09
- Recognizing PsA as a disease 15:20
- An anecdote about Wright 16:18
- Putting the SpA puzzle pieces together 18:19
- The severity of disease 19:08
- Episode wrap-up 20:46
Disclosures: Brown reports no relevant financial disclosures.
We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum
References:
Ankylosing Spondylitis, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1980.
Espinoza LR, Helliwell P. Clinical Rheumatology. 2014;33:1335-1336.
Gladman DD, et al. Q J Med. 1987;62:127-141.
Kane D, et al. Rheumatology. 2003;42:1460-1468.
Moll JMH. Reumatismo. 2007;59 Suppl 1:13-18.
Moll JM, Wright V. Semin Arthritis Rheum. 1973;3:55-78.
Seronegative polyarthritis, North-Holland Pub. Co., New York, Amsterdam, 1976.
Sound effects obtained from https://www.zapsplat.com
Wright V. Am J Med. 1959;27:454-462.